脑部放疗，上午比下午敏感许多！; k H# r& c. P" i. Y, M' m% `+ D
9 A; |2 q+ O7 G2 e$ |
& I* V# F) ^7 r% s
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.6 X% @9 l' ^1 v; |& t
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
. u4 F9 K+ W/ _$ b( l9 sRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
9 s4 g( k* W9 M% M( ASourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
0 u( ?# B) V: L! q
6 F5 V, [1 f4 C# u! jAbstract
( i6 ] A8 `. O- ^2 j. [; j- e! f4 }BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time./ P8 j$ W! j, `& y- [+ j/ r
" A; v* C0 |3 r! Y! ]; [' H! V# p9 P
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
9 [) ^2 I# L' F7 h6 R" c" J, w' L+ j# N6 B+ U
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).. `0 s8 X; Q% }7 A& @( Y
c2 ^2 @; V. R# U& c6 t* h( XCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
/ i$ q! P$ F& R1 `
2 S6 L" I: |( A& s |
显身卡
